JNCE

Jounce Therapeutics, Inc. Common Stock
JNCE

Overview Fund Activity
Delisted

JNCE was delisted on the 3rd of May, 2023.

Back to rankings

115 hedge funds and large institutions have $271M invested in Jounce Therapeutics, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 44 increasing their positions, 35 reducing their positions, and 25 closing their positions.

Holders
115
Holders Change
-15
Holders Change %
-11.54%
% of All Funds
2.02%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
11
Increased
44
Reduced
35
Closed
25
Calls
$570K
Puts
$180K
Net Calls
+$390K
Net Calls Change
+$1.78M

Top Buyers

1
LGM
1
Logos Global Management
California
$14.9M
2
RI
2
RTW Investments
New York
$10.4M
3
PHS
3
PFM Health Sciences
California
$28.6M
4
Goldman Sachs
4
Goldman Sachs
New York
$5.01M
5
O
5
OrbiMed
New York
$19.7M

Top Sellers

1
TGI
1
TRV GP II
Massachusetts
$20M
2
Assenagon Asset Management
2
Assenagon Asset Management
Luxembourg
$1.58M
3
Victory Capital Management
3
Victory Capital Management
Texas
$0
4
CS
4
Credit Suisse
Switzerland
$1.23M
5
TCM
5
Tekla Capital Management
Massachusetts
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Millennium Management
26
Millennium Management
New York
$1.79M -$1.61M -217,091 -47%
Two Sigma Investments
27
Two Sigma Investments
New York
$1.66M -$555K -74,726 -25%
Assenagon Asset Management
28
Assenagon Asset Management
Luxembourg
$1.58M -$3.49M -469,827 -69%
SCM
29
Silverarc Capital Management
Massachusetts
$1.55M -$313K -42,085 -17%
T. Rowe Price Associates
30
T. Rowe Price Associates
Maryland
$1.5M +$116K +15,636 +8%
Wells Fargo
31
Wells Fargo
California
$1.42M +$348K +46,815 +32%
Nuveen Asset Management
32
Nuveen Asset Management
Illinois
$1.3M +$88.1K +11,299 +7%
GIM
33
Granahan Investment Management
Massachusetts
$1.29M -$1.36M -183,642 -51%
Marshall Wace
34
Marshall Wace
United Kingdom
$1.26M -$608K -81,792 -33%
AQR Capital Management
35
AQR Capital Management
Connecticut
$1.24M +$83.5K +11,240 +7%
CS
36
Credit Suisse
Switzerland
$1.23M -$2.86M -384,699 -70%
Mariner
37
Mariner
Kansas
$1.11M +$59 +8 +0%
Charles Schwab
38
Charles Schwab
California
$1.07M -$851K -114,507 -44%
Bank of New York Mellon
39
Bank of New York Mellon
New York
$952K +$192K +25,811 +25%
Connor, Clark & Lunn Investment Management (CC&L)
40
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$898K +$359K +48,302 +67%
SSA
41
Schonfeld Strategic Advisors
New York
$867K -$98.2K -13,228 -10%
YMRC
42
Yorktown Management & Research Company
Virginia
$841K +$421K +56,600 +100%
PAM
43
Panagora Asset Management
Massachusetts
$785K +$95.3K +12,829 +14%
GCP
44
GSA Capital Partners
United Kingdom
$720K +$329K +44,277 +84%
PCM
45
Pathway Capital Management
California
$630K +$182K +24,484 +41%
ZCM
46
Ziegler Capital Management
Illinois
$511K -$17.2K -2,317 -3%
AllianceBernstein
47
AllianceBernstein
Tennessee
$460K – – –
JRP
48
Jasper Ridge Partners
California
$378K +$378K +50,858 New
Principal Financial Group
49
Principal Financial Group
Iowa
$342K -$12.9K -1,736 -4%
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
$316K +$8.66K +1,167 +3%
1
2
3 4 5